HARVARD BIOSCIENCE, INC. Equity Securities, FV-NI, Unrealized Gain (Loss)
HARVARD BIOSCIENCE, INC. (HBIO) reported Equity Securities, FV-NI, Unrealized Gain (Loss) of $1.21 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-07.
Discontinued › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss · last filed 2023-11-07
- HARVARD BIOSCIENCE, INC. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2023-09-30 was $1.21M.
- HARVARD BIOSCIENCE, INC. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2022-09-30 was $0.00.
| Period end | Equity Securities, FV-NI, Unrealized Gain (Loss) 3 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 9 month |
|---|---|---|
| 2023-09-30 | $1.21M 10-Q · filed 2023-11-07 | -$373.00K 10-Q · filed 2023-11-07 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |